228 related articles for article (PubMed ID: 17515331)
1. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
Maswadeh HM; Semreen MH; Abdulhalim AA
Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
[TBL] [Abstract][Full Text] [Related]
2. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
3. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
[TBL] [Abstract][Full Text] [Related]
4. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
5. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
Gohel MC; Amin AF; Patel KV; Panchal MK
Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
[TBL] [Abstract][Full Text] [Related]
6. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
8. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hydrophobic materials as matrices for controlled-release drug delivery.
Quadir MA; Rahman MS; Karim MZ; Akter S; Awkat MT; Reza MS
Pak J Pharm Sci; 2003 Jul; 16(2):17-28. PubMed ID: 16414573
[TBL] [Abstract][Full Text] [Related]
10. Study of the prolonged release of theopylline from polymeric matrices based on grafted chitosan with acrylamide.
Tapia C; Costa E; Terraza C; Munita AM; Yazdani-Pedram M
Pharmazie; 2002 Nov; 57(11):744-9. PubMed ID: 12611277
[TBL] [Abstract][Full Text] [Related]
11. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth.
Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS
Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420
[TBL] [Abstract][Full Text] [Related]
12. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
Miranda A; Millán M; Caraballo I
Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
[TBL] [Abstract][Full Text] [Related]
13. Formulation development and in vitro evaluation of theophylline microcapsules.
Ahmad M; Akhtar N; Murtaza G; Hussain SW
Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
[TBL] [Abstract][Full Text] [Related]
14. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Jannin V; Pochard E; Chambin O
Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
[TBL] [Abstract][Full Text] [Related]
15. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence.
Asare-Addo K; Levina M; Rajabi-Siahboomi AR; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):452-60. PubMed ID: 20729043
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
17. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus.
Wu Y; Ghaly ES
P R Health Sci J; 2006 Mar; 25(1):75-83. PubMed ID: 16883682
[TBL] [Abstract][Full Text] [Related]
20. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
